Is it ethical to offer patients cash to boost hep C treatment?
A new approach is needed if Australia is to stamp out hepatitis C in the next decade, says Professor Mark Stoové
Financial incentives should be used to boost hepatitis C testing rates among difficult to reach patient groups, including people who inject drugs, a leading public health researcher says.
Professor Mark Stoové, head of public health at the Burnet Institute in Melbourne, says “innovative” approaches are needed to boost testing rates and treatment uptake.
